Make the profile of
Inpart yours.

Company description

Inpart is an end-to-end platform for R&D partnerships in the life sciences sector. It unifies data, insights, and teams to help organizations discover, manage, and deliver innovation through external partnerships. The platform is trusted by more than 500 clients across the life sciences industries, including 70% of the top 50 pharmaceutical companies.

Inpart covers every stage of the partnering lifecycle, from initial opportunity scouting and partner discovery through to due diligence, deal management, and long-term alliance oversight. Clients have reported saving up to $4.8 million annually through automated workflows and improved win ratios, more than 24,000 hours saved per year by eliminating duplicated effort, evaluations completed up to three times faster through harmonized data and connected workflows, and up to $50 million in added portfolio value through improved data visibility and decision quality.

Core Platform Capabilities

• Discover: Uncovers new partners and opportunities across a global network of science, supported by personalized landscaping tools to identify relevant external innovation.
• Centralize: Brings together scattered information, cross-functional workflows, and partnership data into one secure, connected system designed for collaboration and dealmaking.
• Harmonize: A data engine that standardizes unstructured taxonomies and fragmented data into comparable, actionable insights. The process covers ingestion, harmonization, creation of a single source of truth, and preparation of data for AI-ready use.
• Integrate: Connects with partnering databases, external systems, and third-party tools to keep information flowing and opportunities moving forward.

Solutions by Team Function

• Open Innovation: Enables organizations to launch challenges, engage external innovators, and capture submissions within a single system.
• Research & Development: Supports sharing of scientific expertise and ensures that incoming opportunities align with strategic R&D priorities.
• Search & Evaluation: Provides structured, reliable data to help teams identify, compare, and prioritize opportunities.
• Business Development: Streamlines deal sourcing and negotiations through connected insights and workflows.
• Due Diligence: Facilitates cross-functional collaboration to evaluate risks, benefits, and strategic fit with clarity.
• Alliance Management: Tracks obligations, performance, and outcomes across active partnerships to maximize long-term value.

Notable Client Outcomes

• UCB Alliance Managers use Inpart to access accurate information and maintain full alliance history — including goals, decisions, and next steps — in one place, as noted by UCB's Alliance & Operations Manager.
• Eli Lilly has used Inpart to standardize processes, enable more consistent data across its External Innovation community, and place data more directly in the hands of business development leadership, according to Lilly's External Innovation Operations Director.

Security and Compliance

• The platform is built with enterprise-grade security standards.
• Inpart is GDPR compliant and supports validated processes to ensure data protection across all partnering activities.

Inpart positions itself as a platform that can be tailored to different departmental needs within life sciences organizations, with partnering experts available to customize solutions for teams beyond the core functions listed above.

AI-generated · replace with your own

Software attributed to Inpart

• InpartView

Edit all with premium access